Research ArticlesTheoretical and Experimental Studies of Transport of Micelle-Solubilized Solutes
References (17)
- et al.
J. Pharm. Sci.
(1964) - et al.
Lancet
(1961) - et al.
J. Pharm. Sci.
(1968) J. Ultrastructure Res.
(1967)- et al.
Biochim. Biophys. Acta
(1971) - et al.
J. Pharm. Sci.
(1974) - et al.
J. Pharm. Sci.
(1968) - et al.
Ann. Intern. Med.
(1948)
There are more references available in the full text version of this article.
Cited by (169)
Mechanistic analysis for positive and negative food effects on oral absorption of poorly soluble drugs from cyclodextrin containing formulations: Study with a mini-scale in vitro system
2022, Journal of Drug Delivery Science and TechnologyApplication of UV dissolution imaging to pharmaceutical systems
2021, Advanced Drug Delivery ReviewsAdequate formulation approach for oral chemotherapy: Etoposide solubility, permeability, and overall bioavailability from cosolvent- vs. vitamin E TPGS-based delivery systems
2021, International Journal of PharmaceuticsEffects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions
2019, European Journal of Pharmaceutics and BiopharmaceuticsEffect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
2019, Journal of Controlled ReleaseCitation Excerpt :In the digestion medium a large proportion of a lipophilic drug molecule, such as carvedilol, is solubilized in colloidal structures formed by lipids and digestion products. Therefore the higher LBF dose mainly resulted in increased carvedilol solubilization, and hence, exemplified a solubility-permeability tradeoff with relatively low free fraction of carvedilol available for absorption [37–39]. However, in vivo, the higher LBF dose (F2) gave significantly higher plasma exposure compared to the lower dose (F3) (Fig. 5 and Table 3).
Copyright © 1982 Wiley-Liss, Inc., A Wiley Company. Published by Elsevier Inc. All rights reserved.